Pear Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:PEAR  
1.94
-0.01 (-0.51%)
4:39:30 PM EDT: $1.94 0.00 (0.00%)
Earnings Announcements

Pear Therapeutics Reports Third Quarter 2022 Results

Published: 11/14/2022 21:53 GMT
Pear Therapeutics Inc - Ordinary Shares - Class A (PEAR) - Q3 Revenue $4.1 Million.
Pear Therapeutics Reports Third Quarter 2022 Results.
Qtrly Loss per Share $0.22.
Sees FY 2022 Net Revenue $14 Million -16 Million.
Proposed Deal for $14-16 Million.
Q3 Earnings per Share View $-0.21, Revenue View $4.0 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $4.79 Million
Adjusted EPS is expected to be -$0.22

Next Quarter Revenue Guidance is expected to be $5.75 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.